(A chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys (Amide bridge: 29-C) (B chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (Disulfide bridge: 6-11, A7-B7, A19-B20) (C chain)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE06 Insulin degludec
D09727 Insulin degludec (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin Degludec
D09727 Insulin degludec (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D09727 Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D09727 Insulin degludec
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D09727 Insulin degludec
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D09727 Insulin degludec (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09727
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09727
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09727
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09727
